Integration between the Tandem Diabetes Care t:slim X2 insulin pump and the Dexcom G7 continuous glucose monitoring (CGM) sensor is currently in development.
There are many factors that influence integration between two products, including development and testing. The Tandem goal is to integrate within 3-6 months of Dexcom receiving FDA clearance for the G7. Tandem will provide an update when the integration is available.
Tandem pumps have successfully integrated with Dexcom G4, G5, and G6 CGMs through the years. Tandem is committed to delivering an integrated solution as quickly as possible.
ZD-000197_A
